976 related articles for article (PubMed ID: 18997771)
1. A role for VEGF as a negative regulator of pericyte function and vessel maturation.
Greenberg JI; Shields DJ; Barillas SG; Acevedo LM; Murphy E; Huang J; Scheppke L; Stockmann C; Johnson RS; Angle N; Cheresh DA
Nature; 2008 Dec; 456(7223):809-13. PubMed ID: 18997771
[TBL] [Abstract][Full Text] [Related]
2. Excess vascular endothelial growth factor-A disrupts pericyte recruitment during blood vessel formation.
Darden J; Payne LB; Zhao H; Chappell JC
Angiogenesis; 2019 Feb; 22(1):167-183. PubMed ID: 30238211
[TBL] [Abstract][Full Text] [Related]
3. Identification of a subset of pericytes that respond to combination therapy targeting PDGF and VEGF signaling.
Hasumi Y; Kłosowska-Wardega A; Furuhashi M; Ostman A; Heldin CH; Hellberg C
Int J Cancer; 2007 Dec; 121(12):2606-14. PubMed ID: 17691110
[TBL] [Abstract][Full Text] [Related]
4. Platelet-derived growth factor receptor-beta constitutive activity promotes angiogenesis in vivo and in vitro.
Magnusson PU; Looman C; Ahgren A; Wu Y; Claesson-Welsh L; Heuchel RL
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2142-9. PubMed ID: 17656670
[TBL] [Abstract][Full Text] [Related]
5. Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment.
Guo P; Hu B; Gu W; Xu L; Wang D; Huang HJ; Cavenee WK; Cheng SY
Am J Pathol; 2003 Apr; 162(4):1083-93. PubMed ID: 12651601
[TBL] [Abstract][Full Text] [Related]
6. Combined VEGF and PDGF inhibition for neovascular AMD: anti-angiogenic properties of axitinib on human endothelial cells and pericytes in vitro.
Siedlecki J; Wertheimer C; Wolf A; Liegl R; Priglinger C; Priglinger S; Eibl-Lindner K
Graefes Arch Clin Exp Ophthalmol; 2017 May; 255(5):963-972. PubMed ID: 28161830
[TBL] [Abstract][Full Text] [Related]
7. VEGFR2-dependent angiogenic capacity of pericyte-like dental pulp stem cells.
Janebodin K; Zeng Y; Buranaphatthana W; Ieronimakis N; Reyes M
J Dent Res; 2013 Jun; 92(6):524-31. PubMed ID: 23609159
[TBL] [Abstract][Full Text] [Related]
8. PDGF and vessel maturation.
Hellberg C; Ostman A; Heldin CH
Recent Results Cancer Res; 2010; 180():103-14. PubMed ID: 20033380
[TBL] [Abstract][Full Text] [Related]
9. Enhancing microvascular formation and vessel maturation through temporal control over multiple pro-angiogenic and pro-maturation factors.
Brudno Y; Ennett-Shepard AB; Chen RR; Aizenberg M; Mooney DJ
Biomaterials; 2013 Dec; 34(36):9201-9. PubMed ID: 23972477
[TBL] [Abstract][Full Text] [Related]
10. Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms.
Erber R; Thurnher A; Katsen AD; Groth G; Kerger H; Hammes HP; Menger MD; Ullrich A; Vajkoczy P
FASEB J; 2004 Feb; 18(2):338-40. PubMed ID: 14657001
[TBL] [Abstract][Full Text] [Related]
11. The role of PDGF receptor inhibitors and PI3-kinase signaling in the pathogenesis of corneal neovascularization.
Dell S; Peters S; Müther P; Kociok N; Joussen AM
Invest Ophthalmol Vis Sci; 2006 May; 47(5):1928-37. PubMed ID: 16639000
[TBL] [Abstract][Full Text] [Related]
12. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves the antiangiogenic efficacy for advanced stage mouse corneal neovascularization.
Chaoran Z; Zhirong L; Gezhi X
Graefes Arch Clin Exp Ophthalmol; 2011 Oct; 249(10):1493-501. PubMed ID: 21574021
[TBL] [Abstract][Full Text] [Related]
13. Sequential delivery of VEGF, FGF-2 and PDGF from the polymeric system enhance HUVECs angiogenesis in vitro and CAM angiogenesis.
Bai Y; Bai L; Zhou J; Chen H; Zhang L
Cell Immunol; 2018 Jan; 323():19-32. PubMed ID: 29111157
[TBL] [Abstract][Full Text] [Related]
14. Rapid vascular regrowth in tumors after reversal of VEGF inhibition.
Mancuso MR; Davis R; Norberg SM; O'Brien S; Sennino B; Nakahara T; Yao VJ; Inai T; Brooks P; Freimark B; Shalinsky DR; Hu-Lowe DD; McDonald DM
J Clin Invest; 2006 Oct; 116(10):2610-21. PubMed ID: 17016557
[TBL] [Abstract][Full Text] [Related]
15. Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis.
Goede V; Schmidt T; Kimmina S; Kozian D; Augustin HG
Lab Invest; 1998 Nov; 78(11):1385-94. PubMed ID: 9840613
[TBL] [Abstract][Full Text] [Related]
16. RGS5 expression is a quantitative measure of pericyte coverage of blood vessels.
Mitchell TS; Bradley J; Robinson GS; Shima DT; Ng YS
Angiogenesis; 2008; 11(2):141-51. PubMed ID: 18038251
[TBL] [Abstract][Full Text] [Related]
17. Pericytes regulate VEGF-induced endothelial sprouting through VEGFR1.
Eilken HM; Diéguez-Hurtado R; Schmidt I; Nakayama M; Jeong HW; Arf H; Adams S; Ferrara N; Adams RH
Nat Commun; 2017 Nov; 8(1):1574. PubMed ID: 29146905
[TBL] [Abstract][Full Text] [Related]
18. Defining Endothelial Cell-Derived Factors That Promote Pericyte Recruitment and Capillary Network Assembly.
Kemp SS; Aguera KN; Cha B; Davis GE
Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2632-2648. PubMed ID: 32814441
[TBL] [Abstract][Full Text] [Related]
19. Platelet-derived growth factor C promotes revascularization in ischemic limbs of diabetic mice.
Moriya J; Wu X; Zavala-Solorio J; Ross J; Liang XH; Ferrara N
J Vasc Surg; 2014 May; 59(5):1402-9.e1-4. PubMed ID: 23856609
[TBL] [Abstract][Full Text] [Related]
20. Vascular wall maturation and prolonged angiogenic effect by endothelial-specific platelet-derived growth factor expression.
Levanon K; Varda-Bloom N; Greenberger S; Barshack I; Goldberg I; Orenstein A; Breitbart E; Shaish A; Harats D
Pathobiology; 2006; 73(3):149-58. PubMed ID: 17085959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
